Recombinant Human Growth Hormone (rhGH) and recombinant Human Insulin-Like Growth Factor-1 (rhIGF-1) Combination Therapy in Children with Short Stature Associated with IGF-` Deficiency: A Six-Year Randomized Multi-Center Open-Label Parallel-Group Ac
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is a dose-finding phase 2 study of the combination of GH and IGF-1 in children with severe short stature, normal GH secretion, and low or low normal IGF-1 levels.
Description
This study is a dose-finding phase 2 study of the combination of GH and IGF-1 in children with severe short stature, normal GH secretion, and low or low normal IGF-1 levels.
Details
| Condition | Growth Hormone Deficiency |
|---|---|
| Age | 5years - 18years |
| Clinical Study Identifier | TX2296 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.